naphazoline has been researched along with Myasthenia Gravis in 2 studies
Naphazoline: An adrenergic vasoconstrictor agent used as a decongestant.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We examined the efficacy of topical naphazoline in the treatment of myasthenic blepharoptosis." | 9.15 | Topical naphazoline in the treatment of myasthenic blepharoptosis. ( Masuda, M; Nagane, Y; Shimizu, Y; Suzuki, N; Suzuki, S; Uchiyama, S; Utsugisawa, K; Utsumi, H, 2011) |
| " We examined the efficacy of topical naphazoline in the treatment of myasthenic blepharoptosis." | 5.15 | Topical naphazoline in the treatment of myasthenic blepharoptosis. ( Masuda, M; Nagane, Y; Shimizu, Y; Suzuki, N; Suzuki, S; Uchiyama, S; Utsugisawa, K; Utsumi, H, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Suzuki, S | 2 |
| Nagane, Y | 1 |
| Utsugisawa, K | 1 |
| Masuda, M | 1 |
| Shimizu, Y | 1 |
| Utsumi, H | 1 |
| Uchiyama, S | 1 |
| Suzuki, N | 1 |
1 review available for naphazoline and Myasthenia Gravis
| Article | Year |
|---|---|
[Treatment of pure ocular myasthenia: a proposal from Japan MG registry 2012].
Topics: Blepharoptosis; Calcineurin Inhibitors; Cholinesterase Inhibitors; Diplopia; Disease Progression; Hu | 2013 |
1 trial available for naphazoline and Myasthenia Gravis
| Article | Year |
|---|---|
Topical naphazoline in the treatment of myasthenic blepharoptosis.
Topics: Administration, Topical; Adult; Aged; Blepharoptosis; Female; Humans; Male; Middle Aged; Myasthenia | 2011 |